12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01370005 · COMPLETED
Trial details
- NCT number
- NCT01370005
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-07-01
- Enrollment
- 825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.